Face coverings optional at Vision Expo East

Article

Javits Center safety requirements updated in line with New York State and New York City guidelines.

Vision Expo East organizers announce that proof of COVID-19 vaccinations and face covering will not be required to attend the March 31-April 3, 2022 event. Health and safety guidelines were updated in response to new requirements of the Javits center, New York State and New York City.

“The health and safety of everyone in attendance at Vision Expo continues to be our priority,” said Fran Pennella, Vice President, Vision Expo at RX. “In accordance with New York State and New York City guidelines, we are pleased to introduce revised protocols for Vision Expo East. We encourage our participants to be up-to-date on COVID-19 vaccinations and ask that anyone who is not up-to-date wear a face covering. We will continue to monitor the guidance of public health authorities and government agencies going forward to ensure we are creating an environment at Vision Expo East that is as safe as possible.”

A comprehensive set of health and safety guidelines for Vision Expo, including policies and resources designed to support a safe experience, known as VisionSAFE, is available here.

All restrictions and requirements are subject to change.

Recent Videos
Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.
Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been prescribing the NutriTears supplement to their dry eye patients.
Damaris Raymondi, OD, FAAO, highlighted the importance of building patient-doctor trust to learn about these practices, which can include non-traditional treatments like chamomile or manuka honey eye drops.
Noreen Shaikh, OD, Magdalena Stec, OD, FAAO, and Brenda Bohnsack, MD, PhD, emphasize that collaboration and communication are key to proper diagnosis and treatment.
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
© 2024 MJH Life Sciences

All rights reserved.